Molbio Diagnostics IPO Analysis - Avoid or Apply? GMP, Valuation & Fundamentals

Описание: Molbio Diagnostics IPO Analysis in detail. In this video, we review the Molbio Diagnostics IPO, including the IPO price band, issue size, GMP, business model, financial performance, valuation, growth prospects, key risks and whether investors should consider applying.

Molbio Diagnostics is a molecular diagnostics company known for its Truenat® point-of-care testing platform and operates across multiple international markets. The IPO comprises a ₹200 crore fresh issue and an offer for sale of around ₹740 crore.

In this video:
• Molbio Diagnostics IPO details
• Price band & lot size
• GMP and expected listing
• Revenue & profit analysis
• Business model
• Growth opportunities
• Valuation analysis
• Personal opinion

Subscribe to our Channel: https://bit.ly/2GnoIJY
Follow on Instagram:   / mdazhar.investing  

Disclaimer: This channel and examples are for teaching purposes only and are not meant as advice/suggestions to trade in these stocks. Mentioning the stocks here does not imply that I have a trading position or am likely to take a trade-in in these stocks. Investing is subjected to market risks, speak to your financial advisor before investing.

Thank you :-)